Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof
US8986701B2 · kind B2 · utility
2Cited by
29References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 19, 2012 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Mar 22, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating cancer by targeting tumor vasculature using an enzyme prodrug cancer therapy treatment are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.